Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 329.48B | 331.13B | 332.59B | 303.92B | 338.57B | 344.05B |
Gross Profit | 125.82B | 127.67B | 123.85B | 110.75B | 158.03B | 162.41B |
EBITDA | 25.34B | 29.06B | 34.05B | 27.93B | 35.09B | 34.36B |
Net Income | 5.45B | 8.11B | 14.13B | 8.10B | 13.52B | 11.84B |
Balance Sheet | ||||||
Total Assets | 357.20B | 377.77B | 395.74B | 369.05B | 356.74B | 340.08B |
Cash, Cash Equivalents and Short-Term Investments | 53.63B | 60.24B | 97.20B | 91.93B | 102.25B | 98.64B |
Total Debt | 162.00M | 165.00M | 30.00B | 30.02B | 30.35B | 30.64B |
Total Liabilities | 91.21B | 105.18B | 132.63B | 124.30B | 115.57B | 117.53B |
Stockholders Equity | 265.43B | 272.00B | 262.54B | 244.29B | 240.79B | 221.75B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -15.66B | 9.69B | -8.89B | 4.89B | 474.00M |
Operating Cash Flow | 0.00 | 1.81B | 28.06B | 16.80B | 28.65B | 17.22B |
Investing Cash Flow | 0.00 | -10.26B | -10.37B | -20.14B | -29.19B | -12.44B |
Financing Cash Flow | 0.00 | -39.15B | -6.09B | -10.28B | -4.86B | -9.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
63 Neutral | $20.53B | 14.81 | -2.64% | 3.11% | 1.95% | -4.97% | |
58 Neutral | €330.84B | 39.63 | 3.19% | 1.76% | 2.44% | -18.02% | |
― | $2.40B | 19.64 | 8.89% | 1.74% | ― | ― | |
― | €1.91B | 11.69 | 10.59% | ― | ― | ― | |
73 Outperform | ¥307.47B | 19.92 | 3.94% | 8.96% | 9.34% | ||
70 Outperform | ¥263.95B | 20.61 | 1.92% | 11.08% | -46.09% | ||
63 Neutral | ¥316.23B | 42.45 | 2.52% | 2.97% | -46.46% |
Ezaki Glico Co., Ltd. announced the establishment of a special purpose company, Glico Europe B.V., in the Netherlands as part of its strategy to pursue global growth investments. This move aligns with the company’s mid-term management plan to expand its business into new areas and promote global growth, with a minor expected impact on the company’s earnings for the fiscal year ending December 31, 2025.